Patient Preference RCT | Short-term anti-TNF therapy with surgical closure vs. anti-TNF therapy alone in the treatment of perianal fistulas in Crohn’s disease.
21 Sep, 2022 | 13:09h | UTCShort-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn’s disease (PISA-II): a patient preference randomised trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)
Podcast: Elise Meima-van Praag on surgical closure for Crohn’s disease perianal fistulas
Commentary: Anti-TNF, surgical closure induces long-term healing in Crohn’s fistulas – Healio (free registration required)
Commentary on Twitter
In our latest issue – Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference randomised trialhttps://t.co/TY8EaZNDig @CRSugergyAUMC #gitwitter #SoMe4Surgery #ibd pic.twitter.com/Y7SY3mTNE9
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) June 20, 2022